Phocas Financial »

Peregrine Pharmaceuticals shares owned by Phocas Financial

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Phocas Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1k 185k 0.01
2023-09-30 $2.3M 245k 9.44
2023-06-30 $2.4M 174k 13.97
2023-03-31 $3.3M 175k 18.76
2022-12-31 $2.4M 174k 13.77
2022-09-30 $3.3M 174k 19.12
2022-06-30 $2.6M 168k 15.26
2022-03-31 $3.5M 170k 20.37
2021-12-31 $3.6M 124k 29.18
2021-09-30 $2.9M 137k 21.57